Association of generalized vitiligo with MHC class II loci in patients from the Indian subcontinent

Journal of Investigative Dermatology

Volumn 133, Issue 5, 2013, Pages 1369-1372

  Birlea, Stanca A ^a   Ahmad, Fridoon J ^b   Uddin, Raza M ^b   Ahmad, Shakil ^b   Pal, Sabrina S ^b   Begum, Rasheedunnisa ^c   Laddha, Naresh C ^c   Dwivedi, Mitesh ^c   Shoab Mansuri, Mohmmad ^c   Jin, Ying ^a,d   Gowan, Katherine ^a   Riccardi, Sheri L ^a   Holland, Paulene J ^a   Ben, Songtao ^a   Fain, Pamela R ^a,d   Spritz, Richard A ^a,d  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b KING EDWARD MEDICAL UNIVERSITY   (Pakistan)

^c M S UNIVERSITY OF BARODA   (India)

^d Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQA1 ANTIGEN; HLA DR ANTIGEN; HLA DRB1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NOTCH4 RECEPTOR;

CHROMOSOME 6P; CONTROLLED STUDY; GENE LOCUS; GENERALIZED VITILIGO; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; INDIA; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VITILIGO;

EID: 84876674168     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.501     Document Type: Letter

References (15)

1. Cortes A, Brown MA (2011) Promise and pitfalls of the immunochip. Arthritis Res Ther 13:101
2. Das SK, Majumder PP, Chakraborty R et al. (1985) Studies on vitiligo. I. Epidemiological profile in Calcutta, India. Genet Epidemiol 2:71-8
3. Handa S, Kaur I (1999) Vitiligo: Clinical findings in 1436 patients. J Dermatol 26:653-7
4. Jin Y, Birlea SA, Fain PR et al. (2010) Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med 362:1686-97
5. Jin Y, Birlea SA, Fain PR et al. (2011) Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset. J Invest Dermatol 131:1308-12
6. Jin Y, Ferrara T, Gowan K et al. (2012) Re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation. J Invest Dermatol 132:1730-3
7. Liu J, Tang H, Zuo X et al. (2012) A single nucleotide polymorphism rs9468925 of MHC region is associated with clinical features of generalized vitiligo in Chinese Han population. J Eur Acad Dermatol Venereol 26:1137-41
8. Mehta NR, Shah KC, Theodore C et al. (1973) Epidemiological study of vitiligo in Surat area, South Gujarat. Indian J Med Res 61:145-54
9. Menon AN (1945) Ultra-violet therapy in cases of leucoderma. Ind Med Gaz 80:612-4
10. Morris AP (2011) Transethnic meta-analysis of genomewide association studies. Genet Epidemiol 35:809-22
11. Parsad D, Dogra S, Kanwar AJ (2003) Quality of life in patients with vitiligo. Health Qual Life Outcomes 1:58
12. Quan C, Ren YQ, Xiang LH et al. (2010) Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet 42:614-8
13. Singh A, Sharma P, Kar HK et al. (2012) HLA alleles and amino-acid signatures of the peptide-binding pockets of HLA molecules in vitiligo. J Invest Dermatol 132:124-34
14. Singh G, Ansari Z, Dwivedi RN (1974) Letter: Vitiligo in ancient Indian medicine. Arch Dermatol 109:913
15. Spritz RA (2012) Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis. J Invest Dermatol 132:268-73